1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Active Pharmaceutical Ingredients (API) Global Market Analysis - Forecast (2014-2020)

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.

This report analyzes the global markets for “Active Pharmaceutical Ingredients (API)“. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance North America (U.S., and Canada), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities.

This report provides:
- Market forecasts for a minimum of 5 years of all the mentioned segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Market share assessments of the top players along with strategic recommendations for the new entrants

Table Of Contents

Active Pharmaceutical Ingredients (API) Global Market Analysis - Forecast (2014-2020)
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 API Market by Manufacturer Type
5.1 Captive
5.2 Merchant

6 API Market by Customer Base
6.1 Generic
6.2 Branded/Innovative

7 API Market by Mode of Synthesis
7.1 Synthetic API
7.2 Biotech API
7.2.1 Monoclonal Antibodies
7.2.2 Recombinant Proteins
7.2.3 Vaccines
7.2.4 Interferons
7.3 HPAPI

8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 Newzealand
8.3.6 Rest of Asia Pacific
8.4 RoW
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions and Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Teva API
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 Covidien Plc
10.3 Aurobindo Pharma
10.4 Ranbaxy Laboratories
10.5 Dr. Reddy'S Laboratories
10.6 Lupin Limited
10.7 Boehringer Ingelheim Gmbh
10.8 Lonza Group
11 Appendix
12 Disclaimer

List of Exhibits
Table 1 Global API Market Analysis, by Region, 2013-2020 ($MN)
Table 2 Global API Market Analysis, by Manufacturer Type, 2013-2020 ($MN)
Table 3 Global API Market Analysis, by Captive, 2013-2020 ($MN)
Table 4 Global API Market Analysis, by Merchant, 2013-2020 ($MN)
Table 5 Global API Market Analysis, by Customer Base, 2013-2020 ($MN)
Table 6 Global API Market Analysis, by Generic, 2013-2020 ($MN)
Table 7 Global API Market Analysis, by Branded/Innovative, 2013-2020 ($MN)
Table 8 Global API Market Analysis, by Synthesis Type, 2013-2020 ($MN)
Table 9 Global API Market Analysis, by Synthetic API , 2013-2020 ($MN)
Table 10 Global API Market Analysis, by Biotech API , 2013-2020 ($MN)
Table 11 Global API Market Analysis, by Monoclonal Antibodies, 2013-2020 ($MN)
Table 12 Global API Market Analysis, by Recombinant Proteins, 2013-2020 ($MN)
Table 13 Global API Market Analysis, by Vaccines, 2013-2020 ($MN)
Table 14 Global API Market Analysis, by Interferons, 2013-2020 ($MN)
Table 15 Global API Market Analysis, by HPAPI , 2013-2020 ($MN)
Table 16 North America API Market Analysis, by Region, 2013-2020 ($MN)
Table 17 North America API Market Analysis, by Manufacturer Type, 2013-2020 ($MN)
Table 18 North America API Market Analysis, by Captive, 2013-2020 ($MN)
Table 19 North America API Market Analysis, by Merchant, 2013-2020 ($MN)
Table 20 North America API Market Analysis, by Customer Base, 2013-2020 ($MN)
Table 21 North America API Market Analysis, by Generic, 2013-2020 ($MN)
Table 22 North America API Market Analysis, by Branded/Innovative, 2013-2020 ($MN)
Table 23 North America API Market Analysis, by Synthesis Type, 2013-2020 ($MN)
Table 24 North America API Market Analysis, by Synthetic API , 2013-2020 ($MN)
Table 25 North America API Market Analysis, by Biotech API , 2013-2020 ($MN)
Table 26 North America API Market Analysis, by Monoclonal Antibodies, 2013-2020 ($MN)
Table 27 North America API Market Analysis, by Recombinant Proteins, 2013-2020 ($MN)
Table 28 North America API Market Analysis, by Vaccines, 2013-2020 ($MN)
Table 29 North America API Market Analysis, by Interferons, 2013-2020 ($MN)
Table 30 North America API Market Analysis, by HPAPI , 2013-2020 ($MN)
Table 31 Europe API Market Analysis, by Region, 2013-2020 ($MN)
Table 32 Europe API Market Analysis, by Manufacturer Type, 2013-2020 ($MN)
Table 33 Europe API Market Analysis, by Captive, 2013-2020 ($MN)
Table 34 Europe API Market Analysis, by Merchant, 2013-2020 ($MN)
Table 35 Europe API Market Analysis, by Customer Base, 2013-2020 ($MN)
Table 36 Europe API Market Analysis, by Generic, 2013-2020 ($MN)
Table 37 Europe API Market Analysis, by Branded/Innovative, 2013-2020 ($MN)
Table 38 Europe API Market Analysis, by Synthesis Type, 2013-2020 ($MN)
Table 39 Europe API Market Analysis, by Synthetic API , 2013-2020 ($MN)
Table 40 Europe API Market Analysis, by Biotech API , 2013-2020 ($MN)
Table 41 Europe API Market Analysis, by Monoclonal Antibodies, 2013-2020 ($MN)
Table 42 Europe API Market Analysis, by Recombinant Proteins, 2013-2020 ($MN)
Table 43 Europe API Market Analysis, by Vaccines, 2013-2020 ($MN)
Table 44 Europe API Market Analysis, by Interferons, 2013-2020 ($MN)
Table 45 Europe API Market Analysis, by HPAPI , 2013-2020 ($MN)
Table 46 APAC API Market Analysis, by Region, 2013-2020 ($MN)
Table 47 APAC API Market Analysis, by Manufacturer Type, 2013-2020 ($MN)
Table 48 APAC API Market Analysis, by Captive, 2013-2020 ($MN)
Table 49 APAC API Market Analysis, by Merchant, 2013-2020 ($MN)
Table 50 APAC API Market Analysis, by Customer Base, 2013-2020 ($MN)
Table 51 APAC API Market Analysis, by Generic, 2013-2020 ($MN)
Table 52 APAC API Market Analysis, by Branded/Innovative, 2013-2020 ($MN)
Table 53 APAC API Market Analysis, by Synthesis Type, 2013-2020 ($MN)
Table 54 APAC API Market Analysis, by Synthetic API , 2013-2020 ($MN)
Table 55 APAC API Market Analysis, by Biotech API , 2013-2020 ($MN)
Table 56 APAC API Market Analysis, by Monoclonal Antibodies, 2013-2020 ($MN)
Table 57 APAC API Market Analysis, by Recombinant Proteins, 2013-2020 ($MN)
Table 58 APAC API Market Analysis, by Vaccines, 2013-2020 ($MN)
Table 59 APAC API Market Analysis, by Interferons, 2013-2020 ($MN)
Table 60 APAC API Market Analysis, by HPAPI , 2013-2020 ($MN)
Table 61 RoW API Market Analysis, by Region, 2013-2020 ($MN)
Table 62 RoW API Market Analysis, by Manufacturer Type, 2013-2020 ($MN)
Table 63 RoW API Market Analysis, by Captive, 2013-2020 ($MN)
Table 64 RoW API Market Analysis, by Merchant, 2013-2020 ($MN)
Table 65 RoW API Market Analysis, by Customer Base, 2013-2020 ($MN)
Table 66 RoW API Market Analysis, by Generic, 2013-2020 ($MN)
Table 67 RoW API Market Analysis, by Branded/Innovative, 2013-2020 ($MN)
Table 68 RoW API Market Analysis, by Synthesis Type, 2013-2020 ($MN)
Table 69 RoW API Market Analysis, by Synthetic API , 2013-2020 ($MN)
Table 70 RoW API Market Analysis, by Biotech API , 2013-2020 ($MN)
Table 71 RoW API Market Analysis, by Monoclonal Antibodies, 2013-2020 ($MN)
Table 72 RoW API Market Analysis, by Recombinant Proteins, 2013-2020 ($MN)
Table 73 RoW API Market Analysis, by Vaccines, 2013-2020 ($MN)
Table 74 RoW API Market Analysis, by Interferons, 2013-2020 ($MN)
Table 75 RoW API Market Analysis, by HPAPI , 2013-2020 ($MN)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

  • $ 6600
  • Industry report
  • November 2016
  • by La Merie Publishing

R&D Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.